ArticleOncogene2021

Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.

Dotan Moskovich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.